# The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

> **NCT03289403** · PHASE2 · COMPLETED · sponsor: **Aljazeera Hospital** · enrollment: 194 (actual)

## Conditions studied

- Infertility
- Autoimmune Thyroiditis

## Interventions

- **DRUG:** Immunomodulatory
- **DRUG:** Thyroxine

## Key facts

- **NCT ID:** NCT03289403
- **Lead sponsor:** Aljazeera Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2023-09-15
- **Final completion:** 2024-01-20
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03289403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03289403, "The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03289403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*